The economic cost of preventable disease in Australia: a systematic review of estimates and methods

Australian and New Zealand Journal of Public Health
Paul CroslandRob Carter

Abstract

The aim of this literature review was to establish the economic burden of preventable disease in Australia in terms of attributable health care costs, other costs to government and reduced productivity. A systematic review was conducted to establish the economic cost of preventable disease in Australia and ascertain the methods used to derive these estimates. Nine databases and the grey literature were searched, limited to the past 10 years, and the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) guidelines were followed to identify, screen and report on eligible studies. Eighteen studies were included. There were at least three studies examining the attributable costs and economic impact for each risk factor. The greatest costs were related to the productivity impacts of preventable risk factors. Estimates of the annual productivity loss that could be attributed to individual risk factors were between $840 million and $14.9 billion for obesity; up to $10.5 billion due to tobacco; between $1.1 billion and $6.8 billion for excess alcohol consumption; up to $15.6 billion due to physical inactivity and $561 million for individual dietary risk factors. Productivity impacts were included in 15 studies and...Continue Reading

References

Sep 27, 2007·International Journal of Obesity : Journal of the International Association for the Study of Obesity·H OkuboUNKNOWN Freshmen in Dietetic Courses Study II group
Mar 6, 2008·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Heather McKay, Everett Smith
May 6, 2009·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·A H AnisC L Birmingham
Mar 6, 2010·The Medical Journal of Australia·Stephen ColagiuriIan D Caterson
Dec 18, 2010·American Journal of Public Health·Anne MagnusRob Carter
Aug 30, 2011·Lancet·Boyd A SwinburnSteven L Gortmaker
Aug 30, 2011·Lancet·Steven L GortmakerMarjory L Moodie
Sep 29, 2011·The International Journal of Behavioral Nutrition and Physical Activity·Dominique A CadilhacAnne Magnus
May 19, 2012·American Journal of Public Health·Anne MagnusRob Carter
Jul 27, 2012·The Journal of Nutrition·James C DoidgeElena Gospodarevskaya
Sep 14, 2012·Drug and Alcohol Dependence·Bruce R SchackmanRochelle P Walensky
Nov 21, 2012·International Journal of Obesity : Journal of the International Association for the Study of Obesity·W W TigbeM E J Lean
Nov 26, 2013·Journal of Child Health Care : for Professionals Working with Children in the Hospital and Community·Murray Drummond, Claire Drummond
Jun 19, 2014·Journal of Child Health Care : for Professionals Working with Children in the Hospital and Community·Murray Drummond, Claire Drummond
Dec 2, 2014·Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals·Margaret J Beavis, Marj Moodie
Aug 12, 2015·Australian and New Zealand Journal of Public Health·Ann RocheVictoria Kostadinov
Sep 12, 2015·International Journal of Adolescent Medicine and Health·Hilary T WolfCharles Kalumuna
Oct 18, 2015·The Lancet Global Health·Joshua A SalomonTheo Vos
Aug 1, 2016·Lancet·Ding DingUNKNOWN Lancet Physical Activity Series 2 Executive Committee
Apr 4, 2018·Vaccine· World Health Organization
Apr 21, 2018·Applied Health Economics and Health Policy·Barbara de GraaffAndrew Palmer
Dec 14, 2018·BMC Medical Informatics and Decision Making·Louise FreebairnLucie Rychetnik

❮ Previous
Next ❯

Citations

Feb 7, 2020·International Journal of Environmental Research and Public Health·Julia CarinsRimante Ronto
Feb 10, 2021·Australian and New Zealand Journal of Public Health·Valerie Kay, Charles Livingstone
Nov 25, 2020·International Journal of Environmental Research and Public Health·Louisa G GordonSandra C Hayes
Nov 2, 2020·Progress in Cardiovascular Diseases·Sisitha JayasingheAndrew P Hills
Apr 27, 2021·Expert Review of Pharmacoeconomics & Outcomes Research·Jakob MantheyJürgen Rehm
May 11, 2021·Journal of Telemedicine and Telecare·Madeline RaatzJoshua Byrnes
Jul 6, 2021·ANZ Journal of Surgery·Chiara ChadwickWendy A Brown
Nov 2, 2021·Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals·Samuel CornellCarissa Bonner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.